Tohoku University

education 📍 Sendai, Japan
Tohoku University
2
Your Condition Name Publications
13
Your Condition Name Researchers

Associated Institutions

Tohoku University Hospital
related
Spintronics Research Network of Japan
child
Institute for Materials Research, Tohoku University
child
Engineering Science Lyon Tohoku, Materials under eXtreme conditions
child

Publications

Co-Occurrence of and Variants in a Patient With Paroxysmal Extreme Pain Disorder, Contradictory Analgesia, and Intractable Paroxysmal Non-Kinesigenic Dyskinesia.

Ikeda M, Kawashima A, Kodama K, Sato R, Uneoka S , et al.
Case reports in medicine •

Gain-of-function mutations in , encoding the voltage-dependent Nav1.7 sodium channel, cause three autosomal-dominant disorders associated with severe pain: primary erythromelalgia, paroxysmal extreme pain disorder (PEPD), and small fiber neuropathy. On the other hand, biallelic loss-of-function mutations have been linked to impaired pain perception. Notably, the coexistence of both hyperalgesia and hypoalgesia within the same patient harboring the I234T variant has been reported in three independent patients to date. We report a 7-year-old girl harboring co-occurring (I234T) and variants who presented with paroxysmal extreme pain disorder, contradictory analgesia, sensitivity to heat, and intractable head-drop attacks. Based on the genetic and clinical analyses, she was diagnosed as having PEPD and -related paroxysmal dyskinesia. The intractable head-drop attacks were considered as paroxysmal non-kinesigenic dyskinesia. In addition, she exhibited easy fatigability and hypotonia. Taken together with her cold, cyanotic feet, these findings suggest that she may have also had small fiber neuropathy.

Successful treatment of adult-onset erythromelalgia with steroid pulse and pregabalin.

Kakizaki A, Fujimura T, Kambayashi Y, Watabe A, Aiba S
Case reports in dermatology •

Adult-onset erythromelalgia (EM) is a rare disease characterized by episodic bouts of burning pain and erythema for which the optimal therapy is unclear. In this report, we describe a 68-year-old Japanese woman with adult-onset EM. Intravenous administration of methylprednisolone sodium succinate 1,000 mg/day dramatically improved her pain as evaluated by the visual analog scale. Although the patient's pain gradually developed again, it could be controlled with pregabalin. Our present case might suggest a possible, optimal therapy for adult-onset EM.